Venture Life Group (LON:VLG) Stock Price Passes Below 200 Day Moving Average – Time to Sell?

Venture Life Group plc (LON:VLG)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 65.56 and traded as low as GBX 65.22. Venture Life Group shares last traded at GBX 66.69, with a volume of 18,037 shares.

Venture Life Group Stock Performance

The firm has a market cap of £80.64 million, a price-to-earnings ratio of 15.26, a PEG ratio of 5.67 and a beta of 0.22. The stock’s fifty day moving average is GBX 67.62 and its two-hundred day moving average is GBX 65.56. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.48 and a current ratio of 4.71.

Insider Buying and Selling

In other news, insider Paul McGreevy bought 93,887 shares of the firm’s stock in a transaction on Tuesday, June 30th. The stock was purchased at an average price of GBX 64 per share, for a total transaction of £60,087.68. In the last ninety days, insiders have bought 174,094 shares of company stock valued at $11,012,928. 7.48% of the stock is currently owned by corporate insiders.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.